Prof Peter Schwarz is President-Elect of the International Diabetes Federation.

Prof Schwarz specialises in the prevention and care of diabetes and is a research group leader at the Paul Langerhans Institute Dresden (PLID), a partner site of the German Center for Diabetes Research (DZD).

NHis research covers molecular and clinical mechanisms to treat and prevent type 2 diabetes. He is also developing and evaluating digital tools such as mobile smartphone applications targeting the common lifestyle-associated risk factors of type 2 diabetes.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received no funding, payments or benefits from any commercial entity.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:	Deutsches Zentrum für Diabetesforschung (DZD), National Institute of Health, European Commission, EU Directorate Public Health, BMBF, BZgA, European Public Health Authorities, SAB, BAYER Vital, Ascensia, Novartis, ASTRA, Lilly, sanofi, AOK, German Diabetes Organisation (DDG), University of Dresden, MSD, Emperra Health Care, Bodytel, Impeto Health Care, vitadio, mebix, Novartis, VIDEAmedical, UNA
Receipt of honoraria or consultation fees:
Participation in a company sponsored speaker’s bureau:	European Commission, AOKplus, AOK, MDK, Ascensia, Novartis, MERCK, Novo, Johnson&Johnson, Lifescan, Lilly, MSD, Boehringer, REHASAN, Servier, sanofi, LEO Pharma, GSK, Boehringer, TUMAINI Institut für Präventionsmanagement, German Diabetes Organisation (DDG), EMPERRA, zanadio, vitadio, DiaExpert, Dexcom, zanadio, International Diabetes Federation; Janssen,
Stock shareholder:	none
Spouse/partner:
Other support (please specify):	Family is 100% shareholder of the TUMAINI Institut für Präventionsmanagement

Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, USA, and his postdoctoral fellowship at INSERM, Paris, France. Professor Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Pediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several publicly funded research projects in the field of diabetes, endocrinology and metabolism, and was awarded the Slovene national award for research in 2014, Gold medal for research at the University of Ljubljana in 2017, the ISPAD Achievement Award in 2020, and the Presidential Medal from Children with Diabetes society in 2022. Professor Battelino serves on the editorial boards for the journals Diabetes Care, Diabetes Technology and Therapeutics, Journal of Pediatric Endocrinology and Metabolism, Acta Diabetologica, and was Editor for the European Journal of Endocrinology from 2009 to 2015. He has authored or co-authored over 343 papers in international peer-reviewed journals and participated chapters to several international books. He has a cumulative h index of 62. Professor Battelino is a member of numerous professional associations including the American Diabetes Association (ADA), European Society for Paediatric Endocrinology (ESPE) and the International Society for Pediatric and Adolescent Diabetes (ISPAD), for which he served as President for the 35th Annual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of sixteen annual meetings of the Advanced Technologies and Treatment of Diabetes - ATTD. He serves as Chair-Elect International Diabetes Federation – Europe (IDF-EU). He is elected Honorary member of the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) and the Hellenic Society of Pediatric and Adolescent Endocrinology (EEPEE). Professor Battelino is a member of the Slovenian Medical Academy, Slovenian Academy of Sciences and Arts (SAZU), and the European Academy of Sciences and Arts.

Dr. Nuha Ali El Sayed is an expert endocrinologist in lifestyle medicine, diabetes prevention, general diabetes, diabetes technology and medical education and training. She received her MD and MBBCh from Alexandria University’s Faculty of Medicine in 2001. She completed her internal medicine residency at Boston University’s Roger Williams Medical Center and a clinical and research fellowship in Diabetes and Obesity at Joslin Diabetes Center, Harvard Medical School in 2007. She completed her clinical training in Endocrinology, Diabetes and Metabolism as a Friedman Fellow at Tufts Medical Center and the Jean Mayer USDA center in 2009.

Dr. El Sayed completed a Master of Medical Sciences in Medical Education at Harvard Medical School in 2019. She holds certificates in clinical investigation from the Sackler School of Biomedical Sciences at Tufts University (2011), Leadership in Healthcare and Medical Education, Medical Education for Health Professions, Medical Education Technology and Systems Approach to Assessments in Health Professions from the Harvard Macy Institute, Harvard Medical School (2017-2018).

At Joslin, Dr. El Sayed sees patients with prediabetes, type 1 and type 2 diabetes with a focus on lifestyle medicine, weight management, and the use of technology in diabetes care. She has a clinical and research interest in medical education, patient education, patient empowerment, and shared decision-making.

Dr. El Sayed oversees Joslin Diabetes Center’s global/professional education, care advisory, and clinical training programs.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received no funding, payments or benefits from any commercial entity.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Ayesha Motala is a specialist physician and is currently Professor in the Department of Diabetes and Endocrinology at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, and Inkosi Albert Luthuli Central Hospital, in Durban, South Africa.

Ayesha is a clinician and her research has focussed on the epidemiology, genetic and clinical aspects of diabetes mellitus and other non-communicable diseases (NCDs). She has been involved in several large - scale population studies, both cross-sectional and longitudinal, on the epidemiology of diabetes mellitus in African (black) and Asian Indian communities in KwaZulu Natal, both urban and rural, She is the lead principal investigator of a large consortium - wide study at 10 sites across 7 countries in sub-Saharan Africa - the Human Hereditary and Health in Africa (H3Africa) study on diabetes, funded through the Wellcome Trust.

She has served as Chairperson of the Society of Endocrinology, Diabetes and Metabolism of South Africa (SEMDSA),and as member of several committees of the International Diabetes Federation (IDF) and World Health Organization (WHO).

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received no funding, payments or benefits from any commercial entity.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:
Receipt of honoraria or consultation fees:
Participation in a company sponsored speaker’s bureau:
Stock shareholder:
Spouse/partner:
Other support (please specify):

Dr. Gaman Ali Mohamed is a highly accomplished diabetologist practicing at the Comprehensive Diabetes Centre. He holds an MBChB from the University of Nairobi and a master's degree in Diabetology from the University of Zagreb in Croatia. Driven by a passion for diabetes management, he specializes in Type 1 Diabetes and utilizes innovative Diabetes Technology to enhance patient care. Recognized for his groundbreaking approach, Dr. Mohamed was honoured with an award by the Kenya Diabetes Study Group (KDSG) for his exceptional use of innovation in managing diabetes.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received funding from the following commercial entities.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:	NA
Receipt of honoraria or consultation fees:	Metronic, Novo. Nordsisk, Servier
Participation in a company sponsored speaker’s bureau:	Metronic
Stock shareholder:	NA
Spouse/partner:	FARAH SHERDEL
Other support (please specify):

Dr Kirtida Acharya MRCP (Ire)MchB(UON)Consultant Physician Endocrinologist Mpshah Hospital Nairobi Kenya, National Chair Diabetes Kenya.

Won Tommy Adamson award and KOGS prize for best student at University of Nairobi

Trained in diabetes and Endocrinology at Aintree University Hospital Liverpool and Glasgow Royal Infirmary UK from 1995 to 2000.

Involved in writing 1st National diabetes strategy and clinical guidelines for Kenya.Comittee member of Kenya NCD alliance. Kenyan representative Pan African Endocrine Society. Published and presented widely at National and international diabetes and endocrine conferences. Supervised numerous postgraduate thesis. Passionate diabetes advocate train all cadres health care workers and set up diabetes clinics in rural Kenya and regularly organised patient empowerment workshops. Co-editor and author of the global diabetes magazine.

Enjoy writing poetry, painting, singing, cooking, and dancing.

Former lecturer University of Nairobi and still an honorary lecturer there and past faculty at Aga Khan

University Hospital Nairobi. Past secretary Kenya Association of physicians.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received no funding, payments or benefits from any commercial entity.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:
Receipt of honoraria or consultation fees:
Participation in a company sponsored speaker’s bureau:
Stock shareholder:
Spouse/partner:
Other support (please specify):

Michelle Carrihill is a paediatrician and endocrinologist, caring for children, adolescents and youth living with diabetes, in both government and private sectors. She advocates for individualised diabetes care, with attention to resource-appropriate, evidence-based quality health care provision. She is long- term supporter of outreach and education of health care providers, teachers and caregivers

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received funding from the following commercial entities.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:	-
Receipt of honoraria or consultation fees:	Eli Lilly; NovoNordisk; Sanofi; Abbotts; Dexcom; Medtronic
Participation in a company sponsored speaker’s bureau:	-
Stock shareholder:	-
Spouse/partner:	-
Other support (please specify):

Dr Reyna Daya is a specialist physician and endocrinologist working in Gauteng. She is a senior clinician in the Department of Internal Medicine and the head of the Division of Endocrinology, Diabetes and Metabolism at Helen Joseph Hospital, a tertiary academic hospital attached to the University of Witwatersrand, Johannesburg, South Africa. Dr Daya also does limited private practice as a specialist endocrinologist at the Sandton Medi-Clinic.

Dr Daya is well known locally having been an invited speaker at CMEs. She is also an invited editor to multiple National Internal Medicine and Endocrinology Journals. In addition, Dr Daya sits on National Drug Advisory Boards for Diabetes. Most recently Dr Daya has been admitted to the prestigious EASD Rising Star Diabetes Academy 2020. Dr Daya is part of the SEMDSA executive committee where she heads the education portfolio.

Dr Daya clinical and research interest is in pregnancy associated endocrine disorders, thyroid ultrasonography, diabetes, phaeochromocytomas and acromegaly. She is well published in the field of Diabetes and Endocrinology and holds a Masters in Medicine from University of the Witwatersrand. Dr Daya is currently working on multiple diabetes related studies as well as supervising Masters students and a number of publications.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received funding from the following commercial entities.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:	N/A
Receipt of honoraria or consultation fees:	Sanofi, Servier, Novo Nordisk
Participation in a company sponsored speaker’s bureau:	Abbot, Aspen, AZ, BI, Eli Lilly, Novartis, Novo Nordisk, Sanofi, Servier, Roche
Stock shareholder:	N/A
Spouse/partner:	N/A
Other support (please specify):

Dr Zaheer Bayat is a specialist physician and endocrinologist working in Gauteng. He is the Head of Department of Internal Medicine at Helen Joseph Hospital, a tertiary academic hospital attached to the University of Witwatersrand, Johannesburg, South Africa. In addition, he is the Acting Academic Head of Endocrinology, Diabetes and Metabolism at Wits University. He is also a clinician in private practice at the Centre for Integrative Health based in the Sandton Medi-Clinic and the Ahmed Kathrada Private Hospital. Dr Bayat is also a director at the Lenasia Clinic Trial and Research Unit (LCTC).

Dr Bayat is the past chairperson of the Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) and was part of the International Congress of Endocrinology organizing committee in 2018. He is a contributor and part of the editorial panel of the South African Type 2 Diabetes Guidelines as well as the South African Thyroid Guidelines.

Dr Bayat is well known locally and internationally, having been an invited speaker and chair to the World Internal Medicine Congress (2018), International Congress of Endocrinology (2018), EASD symposium (2018, 2017) as well as having been part of the Diabetes Education Program in Sub Saharan Africa. He is an invited reviewer to multiple National Internal Medicine and Endocrinology Journals. In addition, Dr Bayat sits on several Regional and National Drug Advisory Boards as well as Diabetes and Thyroid Advisory Panels.

Dr Bayat’s research interest is in diabetes, thyroid and adrenal diseases.

Declaration of Conflict of Interest:	Declaration of financial support:
The author has received funding from the following commercial entities.	No fees were paid to the author for contributions to the IDF School of Diabetes.

Type of affiliation / financial interest	Name (s) of commercial company (-ies)
Receipt of grants/research supports:	Abbot, Sanofi, Aspen, Novartis, Astra
Receipt of honoraria or consultation fees:	Aspen, BI, Az, Medtronic, Merk, MSD, Novartis, Servier, Sanofi, Novo
Participation in a company sponsored speaker’s bureau:	Abbot, Aspen, AZ, BI, Lilly, Medtronic, MSD, Novartis, Novo, Pfizer, Sanofi, Servier
Stock shareholder:	N/A
Spouse/partner:	N/A
Other support (please specify):